These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 9064908)

  • 1. [Current trends in the biological therapy of malignant tumors].
    Khanson KP; Afanas'ev BV; Bershteĭn LM; Blinov NN; Gershanovich ML; Imianitov EN; Moiseenko VM; Okulov VB; Togo AV
    Vopr Onkol; 1996; 42(5):7-12. PubMed ID: 9064908
    [No Abstract]   [Full Text] [Related]  

  • 2. Prospects for tumour therapy using gene transfer.
    Collins MK; Patel P; Flemming CL; Eccles SA
    Bone Marrow Transplant; 1992; 9 Suppl 1():171-3. PubMed ID: 1504662
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunotherapeutic strategies for neoplasia.
    Talmadge JE
    Dev Biol Stand; 1992; 77():17-28. PubMed ID: 1426659
    [No Abstract]   [Full Text] [Related]  

  • 4. IL-2 gene transduction in malignant cells: applications in cancer containment.
    Roth C; Mir L; Cressent M; Quintin-Colonna F; Ley V; Fradelizi D; Kourilsky P
    Bone Marrow Transplant; 1992; 9 Suppl 1():174-5. PubMed ID: 1504663
    [No Abstract]   [Full Text] [Related]  

  • 5. Cancer vaccines in gene therapy.
    Blankenstein T; Qin Z
    Gene Ther; 1996 Feb; 3(2):95-6. PubMed ID: 8867856
    [No Abstract]   [Full Text] [Related]  

  • 6. [Current issues in immunotherapy of tumors in the context of macrophage reaction to tissue damage fixed through evolution].
    Okulov VB
    Vopr Onkol; 1997; 43(1):102-6. PubMed ID: 9133074
    [No Abstract]   [Full Text] [Related]  

  • 7. Molecular approaches to cancer immunotherapy.
    Forni G; Cavallo F; Consalvo M; Allione A; Dellabona P; Casorati G; Giovarelli M
    Cytokines Mol Ther; 1995 Dec; 1(4):225-48. PubMed ID: 9384678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological response modifiers.
    Clark JW
    Cancer Chemother Biol Response Modif; 1996; 16():239-73. PubMed ID: 8639384
    [No Abstract]   [Full Text] [Related]  

  • 9. Biological response modifiers.
    Clark JW
    Cancer Chemother Biol Response Modif; 1993; 14():207-26. PubMed ID: 8312103
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunotherapy-based treatment strategies for malignant mesothelioma.
    Schwarzenberger P; Byrne P; Kolls JK
    Curr Opin Mol Ther; 1999 Feb; 1(1):104-11. PubMed ID: 11249674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thymus hormones in the immunotherapy of malignant neoplasms (a review of the literature)].
    Nikol'skiĭ IS
    Vrach Delo; 1988 Aug; (8):77-82. PubMed ID: 3061171
    [No Abstract]   [Full Text] [Related]  

  • 12. Biological response modifiers: preclinical and clinical results.
    Talmadge JE; Clark J
    Cancer Chemother Biol Response Modif; 1987; 9():454-72. PubMed ID: 3079413
    [No Abstract]   [Full Text] [Related]  

  • 13. [Current data on immunotherapy].
    Tigaud JM; Duarte A; Psyche S; Droz JP
    Rev Infirm; 1991 Dec; 41(19):30-1. PubMed ID: 1771342
    [No Abstract]   [Full Text] [Related]  

  • 14. Targeting gene therapy--a reality?
    Dranoff G
    Mol Ther; 2000 Feb; 1(2):117-8. PubMed ID: 10933921
    [No Abstract]   [Full Text] [Related]  

  • 15. What's new in surgical oncology: impact of immunology and tumour biology.
    Heys SD; Eremin O
    J R Coll Surg Edinb; 1990 Dec; 35(6):341-4. PubMed ID: 2086793
    [No Abstract]   [Full Text] [Related]  

  • 16. Natural killer cell-based immunotherapy in cancer: current insights and future prospects.
    Sutlu T; Alici E
    J Intern Med; 2009 Aug; 266(2):154-81. PubMed ID: 19614820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Locoregional treatment of malignant hepatic tumors with biologic response modifiers.
    Yamamoto A; Sato T
    Surg Oncol Clin N Am; 2008 Oct; 17(4):935-55, xii. PubMed ID: 18722927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immuno-viral therapy of brain tumors by combination of viral therapy with cancer vaccination using a replication-conditional HSV.
    Toda M; Iizuka Y; Kawase T; Uyemura K; Kawakami Y
    Cancer Gene Ther; 2002 Apr; 9(4):356-64. PubMed ID: 11960286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of cell engineering technology to the tumour immunotherapeutic drug: a review.
    Chen ZN; Xing JL; Bian HJ; Mi L; Jiang JL
    Cell Biol Int; 2001; 25(10):1013-5. PubMed ID: 11589619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological therapy in cancer.
    Idowu OE
    Niger J Med; 2001; 10(3):102-5. PubMed ID: 11806006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.